This page may have documents that can’t be read by screen reader software. For help with these documents, please call 1-800-975-6314.

COVID-19 Update: Telehealth and Treatment Cost-Share Waivers Extended

August 14, 2020

We continue to monitor the COVID-19 pandemic and are committed to helping our employer customers and members stay informed. We have updates to some of our coverage dates. As always, members should call the number on their ID card for answers to their specific benefit questions. 

Two new extensions are planned:

  • The cost-share waivers for telehealth will be extended through Sept. 30, 2020.
  • COVID-19 treatment waivers will be extended through Oct. 23, 2020.

Currently, there is no projected end date for the Office of Superintendent of Insurance (OSI) rule that requires cost-share waiver for COVID-19-related testing and treatment for fully insured and Interagency Benefits Advisory Council (IBAC) members. 

Initiative

Effective Date

Projected End Date

COVID-19 Testing

3/7/20

Cost-share waiver ends with the end of the Health and Human Services (HHS) public health emergency

For fully insured and IBAC members: There is no end date for New Mexico’s rule requiring cost-share waiver for COVID-19-related testing and treatment

COVID-19 Testing-related Visits

3/18/20

Cost-share waiver ends with the end of HHS public health emergency.

For fully insured and IBAC members: There is no end date for New Mexico’s rule requiring cost-share waiver for COVID-19-related testing and treatment

Telehealth/Telemedicine

3/18/20

Members will have access to the expanded telemedicine services through 12/31/20, but the cost-share waiver will end on 9/30/20. Copays, deductibles and coinsurance will apply after 9/30/20*. (The requirements of the OSI will continue to apply to COVID-19-related testing and treatment delivered by telemedicine for fully insured and IBAC members.)

For Medicare (not Part D) and Medicare Supplement plans, cost-share waiver extended through 12/31/20*

COVID-19 Treatment

4/1/20

Cost-share waiver extended through 10/23/20* (and beyond 10/23/20 for COVID-19-related testing and treatment for fully insured and IBAC members)

*Date change/extension